Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan, China And Korea To Work Together Towards Clinic Trials Data Sharing

This article was originally published in PharmAsia News

Executive Summary

Drug regulatory directors from Japan, China and Korea held a joint meeting in Tokyo April 14 to promote sharing clinical trial data among the three countries. Japan's Pharmaceutics and Food Safety Bureau Chief and directorial officers from the Korean FDA and China's State FDA agreed to exchange information and to conduct a joint research project on the difference in ethnicities, the biggest barrier to sharing clinical trials data. The three countries also set up a working group to promote joint research projects. (Click here for more - Japanese language

You may also be interested in...



Insider Analysis From Fountain Medical Development: Clinical Development in China - Current Status And Future Trends

By Joanne Jiang, Ph.D, Fountain Medical Development Ltd

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068210

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel